EXCLUSIVE PATENT LICENSE AGREEMENTExclusive Patent License Agreement • June 12th, 2017 • Therapeutic Solutions International, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledJune 12th, 2017 Company Industry JurisdictionThis Exclusive Patent License Agreement (the “Agreement” and/or “EPLA”) is made and entered into by and between Therapeutic Solutions International, Inc., a corporation organized under Nevada law (hereinafter the “Licensor”), having its principle office at 4093 Oceanside Blvd., Suite B, Oceanside CA, 92056, and Emvolio, Inc., a corporation organized under the laws of Delaware (hereinafter the “Licensee”), its principle office being located in Oceanside, California. Licensor and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” The Parties agree as follows:
DISTRIBUTION AGREEMENTDistribution Agreement • June 18th, 2013 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledJune 18th, 2013 Company Industry JurisdictionThis Distribution Agreement (the “Agreement”) is entered into as of June 14, 2013, between S4S (UK) Limited, (“S4S”) a corporation organized under the laws of England, with principal offices at Norton House, 752A Chesterfield Road, Woodseats, Sheffield S8 0SE UK (S4S), and Therapeutic Solutions International, Inc., a corporation organized under the laws of Nevada, USA (“Distributor”), with principal offices at 4093 Oceanside Boulevard, Suite B, Oceanside, California 92056, USA.
LICENSE AGREEMENTLicense Agreement • August 30th, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledAugust 30th, 2012 Company Industry JurisdictionThis License Agreement (“Agreement”) is entered into effective as of August 24, 2012 (the “Effective Date”) by and between Boyd Research, Inc., a California corporation, and TMD Courses, Inc., a California corporation (collectively, “Licensor”) and Therapeutic Solutions International, Inc., a Nevada corporation (“TSOI”) (each a “Party” and collectively, the “Parties”).
ASSETS PURCHASE AGREEMENTAssets Purchase Agreement • December 10th, 2014 • Therapeutic Solutions International, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledDecember 10th, 2014 Company Industry JurisdictionSeparately, Seller also owns all legal right, title and interest in certain intellectual property, product research and development, know-how and related information, as is more fully described in this Agreement, including, but not limited to, a nutritional supplement product known under the trade name: “Projuvenol.”
MASTER DISPUTE RESOLUTION AGREEMENTMaster Dispute Resolution Agreement • August 30th, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledAugust 30th, 2012 Company Industry JurisdictionThis Master Dispute Resolution Agreement (“Agreement”) is entered into effective as of August 24, 2012 (the “Effective Date”) by and among Boyd Research, Inc., a California corporation (“BR”), TMD Courses, Inc., a California corporation (“TMD”) and James P. Boyd (“Boyd,” and, collectively with BR and TMD, the “Boyd Parties”); Therapeutic Solutions International, Inc., a Nevada corporation (“TSOI”); Timothy G. Dixon (“Dixon”); and Gerry B. Berg (“Berg” and, collectively with TSOI and Dixon, the “TSOI Parties”) (each a “Party” and collectively, the “Parties”).
ESCROW AGREEMENTEscrow Agreement • August 30th, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledAugust 30th, 2012 Company Industry JurisdictionThis Escrow Agreement is made as of the 24th day of August, 2012, by and among Therapeutic Solutions International, Inc., a Nevada corporation (“TSOI”), James P. Boyd (“Boyd”) and Chicago Title Company, as escrow agent (the “Escrow Agent”). This Agreement is irrevocable. It is designed and intended to implement certain provisions of the Master Dispute Resolution Agreement of even date herewith among TSOI, Boyd and others.
INVESTOR RELATIONS CONSULTING AGREEMENTInvestor Relations Consulting Agreement • October 31st, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledOctober 31st, 2012 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) effective as of June 17, 2011 is entered into by and between Therapeutic Solutions International, Inc., a Nevada Corporation (herein referred to as the “Company”) and Constellation Asset Advisors, Inc. a Nevada Corporation (herein referred to as “CAA” or the “Constellation”) or it’s successors, designees or assignees, and replaces and supercedes any and all other agreements between the above parties.
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • October 31st, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledOctober 31st, 2012 Company Industry JurisdictionThis Agreement is made April 01, 2011 by and between Boyd Research, Inc. (referred to as "LICENSOR"), a company organized and existing under the laws of California and having a principal place of business of at 7060 Via del Charro, Rancho Sante Fe, CA 92067 and Therapeutic Solutions International Inc. ("LICENSEE"), a corporation organized and existing under the laws of Nevada and having a principal place of business at 4093 Oceanside Blvd. Suite B, Oceanside, CA 92056.
EMPLOYMENT AGREEMENTEmployment Agreement • October 31st, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledOctober 31st, 2012 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT is entered into and effective as of November 15, 2011 (the “Effective Date”), by and between Therapeutic Solutions International, Inc., a Nevada corporation (the “Company”), with its principal place of business at 4093 Oceanside Blvd, Oceanside, CA 92056 and Gerry B. Berg, an individual residing at 1568 Avenida La Posta, Encinitas, CA 92024 (“Mr. Berg”), with reference to the following facts:
TERM SHEET For an exclusive license Agreement (the “Agreement”)Exclusive License Agreement • January 25th, 2016 • Therapeutic Solutions International, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJanuary 25th, 2016 Company IndustryGutave Roussy Transfert having its principal administrative offices at 39 rue Camille Desmoulins 94850 Villejuif (hereinafter “GRT”), and
EMPLOYMENT AGREEMENTEmployment Agreement • October 31st, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • California
Contract Type FiledOctober 31st, 2012 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT is entered into and effective as of November 15, 2011 (the “Effective Date”), by and between Therapeutic Solutions International, Inc., a Nevada corporation (the “Company”), with its principal place of business at 4093 Oceanside Blvd, Oceanside, CA 92056 and Timothy G. Dixon, an individual residing at 177 Warner St., Oceanside CA, 92058 (“Mr. Dixon”), with reference to the following facts:
VOTING AGREEMENTVoting Agreement • August 30th, 2012 • Therapeutic Solutions International, Inc. • Services-business services, nec • Nevada
Contract Type FiledAugust 30th, 2012 Company Industry JurisdictionThis VOTING AGREEMENT (this “Agreement”), is made and entered into on and as of August 24, 2012, by and between Therapeutic Solutions International, Inc., a Nevada corporation (“TSOI”), and James P. Boyd (“Stockholder”).
SHAREHOLDER RIGHTS AGREEMENTShareholder Rights Agreement • March 27th, 2023 • Therapeutic Solutions International, Inc. • Surgical & medical instruments & apparatus • Nevada
Contract Type FiledMarch 27th, 2023 Company Industry JurisdictionTHIS SHAREHOLDER RIGHTS AGREEMENT (the “Agreement” and/or “Shareholder Agreement”), is made by and among __________________________________ (“TSOI Investor” and/or “Share2”), Therapeutic Solutions International, Inc., (“TSOI” and/or “Share1”), hereinafter sometimes referred to individually as a “Shareholder” and collectively as the “Shareholders”) and Campbell Neurosciences, Inc., a Delaware corporation (the “Company” and/or “CNSI”).